Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Cumberland Pharmaceuticals' Profit After Tax fell 2622.69% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 6937.55%. This contributed to the annual value of -$6.5 million for FY2024, which is 235.36% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Profit After Tax stood at -$1.9 million for Q3 2025, which was down 2622.69% from -$740740.0 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Profit After Tax peaked at $1.3 million during Q1 2025, and registered a low of -$6.3 million during Q4 2023.
  • Its 5-year average for Profit After Tax is -$1.3 million, with a median of -$1.4 million in 2022.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Profit After Tax surged by 17316.29% in 2021 and then plummeted by 111270.81% in 2024.
  • Cumberland Pharmaceuticals' Profit After Tax (Quarter) stood at -$4.4 million in 2021, then skyrocketed by 43.94% to -$2.5 million in 2022, then crashed by 156.21% to -$6.3 million in 2023, then skyrocketed by 69.79% to -$1.9 million in 2024, then dropped by 2.38% to -$1.9 million in 2025.
  • Its Profit After Tax stands at -$1.9 million for Q3 2025, versus -$740740.0 for Q2 2025 and $1.3 million for Q1 2025.